mL; or multi-dose (10-20) with multi-dose container with a taste (e.g. sweet). in plastic tubes. a dropper presentation with a dropper device with 10-20 If injectable administration, If injectable administration, maximal dosage volume of doses. vaccine is provided as a liquid vaccine is provided as a liquid 0.05 mL (1 drop) or 0.1 mL (2 If injectable administration, product in mono-dose or or lyophilized product in drops); with favorable taste vaccine is provided as a liquid multi-dose (2) presentations mono-dose or multi-dose (e.g. sweet). or lyophilized product in with a maximal dosage volume presentations with a If injectable administration, mono-dose or multi-dose maximal dosage volume of 0.5 of 0.5 mL. vaccine is provided as a liquid presentations with a mL. Multi-dose presentations product in 10-dose volume of 0.5 mL. should be formulated, Multi-dose presentations presentation with a volume of Multi-dose presentations managed and discarded in should be formulated, 0.5 mL. should be formulated, compliance with WHO’s managed and discarded in Multi-dose presentations managed and discarded in vial policy. compliance with WHO’s should be formulated, compliance with WHO’s vial policy. managed and discarded in vial policy. If not supplied in a dual-barrel compliance with WHO’s If not supplied in a dual-barrel syringe, lyophilized vaccine vial policy. syringe, lyophilized vaccine will need to be accompanied will need to be accompanied by paired separate vials of the by paired separate vials of the appropriate diluent. appropriate diluent. Registration and Should be WHO pre-qualified according to the process outlined Should be WHO pre-qualified according to the process outlined in Procedures for assessing the acceptability, in principle, of Prequalification in Procedures for assessing the acceptability, in principle, of vaccines for purchase by United Nations agencies. vaccines for purchase by United Nations agencies.
mL; or multi-dose (10-20) with a dropper presentation with a maximal dosage volume of 0.05 mL (1 drop) or 0.1 mL (2 drops); with favorable taste (e.g. sweet). If injectable administration, vaccine is provided as a liquid product in 10-dose presentation with a volume of 0.5 mL. Multi-dose presentations should be formulated, managed and discarded in compliance with WHO’s vial policy. multi-dose container with a dropper device with 10-20 doses. If injectable administration, vaccine is provided as a liquid or lyophilized product in mono-dose or multi-dose presentations with a volume of 0.5 mL. Multi-dose presentations should be formulated, managed and discarded in compliance with WHO’s vial policy. If not supplied in a dual-barrel syringe, lyophilized vaccine will need to be accompanied by paired separate vials of the appropriate diluent. taste (e.g. sweet). If injectable administration, vaccine is provided as a liquid product in mono-dose or multi-dose (2) presentations with a maximal dosage volume of 0.5 mL. Multi-dose presentations should be formulated, managed and discarded in compliance with WHO’s vial policy. in plastic tubes. If injectable administration, vaccine is provided as a liquid or lyophilized product in mono-dose or multi-dose presentations with a maximal dosage volume of 0.5 mL. Multi-dose presentations should be formulated, managed and discarded in compliance with WHO’s vial policy. If not supplied in a dual-barrel syringe, lyophilized vaccine will need to be accompanied by paired separate vials of the appropriate diluent. Registration and Prequalification Should be WHO pre-qualified according to the process outlined in Procedures for assessing the acceptability, in principle, of vaccines for purchase by United Nations agencies. Should be WHO pre-qualified according to the process outlined in Procedures for assessing the acceptability, in principle, of vaccines for purchase by United Nations agencies.
Plague_Vaccine_TPP_Online_Consultation.docx